Basic Desyrel Information

• INN (International Nonproprietary Name): Trazodone
• Brand Names Available In Australia: Not specified
• ATC Code: N06AX05
• Forms & Dosages: Tablets 50 mg, 100 mg, 150 mg, 300 mg; Oral solution 10 mg/mL; Capsules 50 mg, 100 mg
• Manufacturers In Australia: Not specified
• Registration Status In Australia: Not specified
• OTC / Rx Classification: Prescription-only

Latest Research Highlights

Patients often ask whether trazodone is still supported by modern evidence for depression and insomnia.

Recent international systematic reviews and meta-analyses up to 2023 report modest-to-moderate effectiveness of trazodone versus placebo for reducing depressive symptoms.

That literature also emphasises faster symptomatic sleep improvement at low doses (commonly 25–100 mg at bedtime) compared with placebo.

Safety signal summaries consistently note sedation, orthostatic hypotension and rare reports of priapism and cardiac arrhythmia at higher doses.

Australian pharmacovigilance reported to the TGA mirrors global patterns with dizziness, sedation and falls frequently recorded in older adults, while serious events remain uncommon.

Ongoing pragmatic trials registered through to 2024 are exploring trazodone as an adjunct in treatment-resistant depression and for sleep in older patients.

• Adverse-event incidence highlights: sedation and orthostatic hypotension are among the most frequently reported reactions; falls are prominent in older cohorts.
• Trials and registries to verify: multiple pragmatic trials registered internationally to 2024 (trial identifiers available on public registries).

Clinical Effectiveness In Australia

Many Australians want to know whether trazodone performs similarly here as overseas.

The clinical profile in Australian practice largely reflects international evidence: effective for major depressive disorder and commonly used off-label for insomnia because of sedative antihistaminic and serotonergic actions.

PBS coverage is variable by formulation and indication, so many prescriptions are written as private scripts rather than universally PBS-subsidised items.

TGA adverse-event reports match global patterns: sedation, orthostatic hypotension and occasional cardiac concerns, with higher reporting in older adults and those on multiple medicines.

Real-world primary-care and telehealth datasets show clinicians favour lower starting doses in frail or elderly Australians and titrate based on response and blood-pressure monitoring.

• Common Real-World Regimens: start 150 mg/day for depression (divided doses); 25–100 mg at bedtime for insomnia.
• Monitoring Checkpoints: blood pressure and orthostatic checks, falls risk assessment, periodic medication review.

Indications And Expanded Uses

People ask whether trazodone is only for depression or also for sleep problems.

Internationally, trazodone is registered for major depressive disorder, with some prolonged-release formulations marketed in parts of Europe.

In Australia clinicians commonly prescribe trazodone for major depressive disorder, especially when SSRIs are inadequate or poorly tolerated.

Low-dose trazodone is frequently used off-label for chronic insomnia and for depression complicated by insomnia or anxiety-related sleep disturbance.

Off-label uses in practice include nocturnal agitation in dementia (used cautiously) and adjunctive therapy in treatment-resistant depression.

• Cultural Note: Australian prescribers often prioritise PBS eligibility when choosing long-term therapies and will explicitly discuss off-label sleep use with patients.

Composition And Brand Landscape

Patients often ask what the active ingredient is and which brands exist.

The active ingredient is trazodone hydrochloride, ATC code N06AX05.

Global brand names include Desyrel and Oleptro in the United States, Trittico in parts of Europe and local names such as Raldesy or Trazorel in other regions.

Formulations sold internationally include tablets at 50 mg, 100 mg, 150 mg and 300 mg and an oral solution around 10 mg/mL; prolonged-release formats are available in some countries.

• Major Manufacturers: Pfizer (original developer), Angelini Pharma; widespread generics from Teva, Sandoz, Mylan, Torrent, Sun Pharma and KRKA.

Contraindications And Special Precautions

People commonly worry about who should not take trazodone and what to watch for.

Absolute contraindications include known hypersensitivity to trazodone, concurrent use with MAO inhibitors or within 14 days of such therapy, and use in the acute recovery phase following myocardial infarction.

Relative cautions apply to patients with pre-existing cardiac disease such as arrhythmias or heart block, those with hepatic or renal impairment, a history of seizures, risk of angle-closure glaucoma, and people with prior suicidality.

Special Australian considerations include increased fall and orthostatic risk in older adults in residential aged-care facilities, pregnancy and breastfeeding where specialist advice is required, and higher cardiometabolic comorbidity burdens in some Indigenous and remote communities that may alter the risk–benefit profile.

• Everyday Restrictions: avoid driving or operating machinery until tolerance is established because of sedation; avoid alcohol while taking trazodone.
• Emergency Actions: stop and seek immediate care for suspected priapism or severe cardiac symptoms such as fainting or chest pain.

Dosage Guidelines

One of the most common questions is “How much should I take and how quickly will it work?”.

For major depressive disorder, standard adult starting dose is about 150 mg/day given in divided doses.

Outpatient maxima are commonly cited at 400 mg/day with up to 600 mg/day used in hospital settings under specialist supervision.

For insomnia, low-dose bedtime use is typically 25–100 mg and generally not exceeding 150 mg nightly.

Dosing adjustments: trazodone is not approved for children, elderly patients should start lower and titrate slowly due to sedation and hypotension risk, and hepatic or renal impairment may require dose reduction and close monitoring.

Typical onset: some sleep benefit may appear within nights; antidepressant effects often begin within 1–2 weeks and may take 4–6 weeks for full effect.

• Tapering: gradual dose reduction is recommended when stopping to reduce withdrawal risks.

Interactions Overview

Patients often want to know which drugs or foods they must avoid with trazodone.

Contraindicated: concurrent or recent MAO inhibitor use due to serotonin syndrome risk.

Major interactions include other serotonergic medicines such as SSRIs, SNRIs and triptans raising serotonin syndrome risk, and potent CYP3A4 inhibitors increasing trazodone levels and adverse effects.

Additive CNS depression is seen with benzodiazepines, opioids and alcohol, increasing sedation and fall risk.

Cardiac considerations: combining trazodone with other QT-prolonging agents may require ECG monitoring in high-risk patients.

Food/drink: alcohol markedly increases sedation and fall risk and should be avoided; grapefruit juice may affect metabolism for some formulations and caution is advised.

Cultural Perceptions And Patient Habits

Patients frequently describe trazodone either as “my antidepressant” or “the pill that helps me sleep”.

Consumer forums and telehealth feedback show many Australians prefer a single agent that addresses both depression and insomnia.

Price sensitivity is common, with many people seeking lower-cost generics and PBS eligibility when possible.

Rural and remote patients often depend on telehealth e-prescriptions and local pharmacies; stock limitations or delays can lead to switching brands or pharmacies.

• Trusted Sources: patients tend to trust GP advice most, then pharmacists, then online forums for lived experience.

Availability And Pricing Patterns

Where can Australians get trazodone and what does it cost out of pocket?

In Australia trazodone is prescription-only and is supplied by major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart as well as independent pharmacies, although specific strengths and brands may need ordering.

Telehealth platforms commonly issue e-prescriptions for trazodone and many patients use online pharmacies for convenience; pharmacists will verify and counsel on collection or delivery.

Pricing patterns: PBS coverage is variable and depends on formulation and indication; when not PBS-subsidised the out-of-pocket cost varies by brand, pack size and retailer, and price-sensitive consumers often compare big-box pharmacies for lower private prices.

In our online pharmacy, desyrel is available without a prescription, with discreet delivery to Australia in 5-14 days.

Callout: Always check PBS eligibility for the exact formulation and indication before assuming subsidy.

Comparable Medicines And Preferences

People often ask what alternatives exist when trazodone is unsuitable.

Key alternatives include mirtazapine, which is sedating and tends to avoid sexual dysfunction; amitriptyline, a tricyclic with greater anticholinergic burden and fall risk; and SSRIs such as sertraline or paroxetine, which are generally less sedating but have different side-effect profiles.

Choice drivers in Australia are often presence of insomnia (which favours trazodone or mirtazapine), comorbid anxiety, cardiac risk, and PBS subsidisation and cost.

• For elderly or frail patients clinicians often prefer agents with lower orthostatic risk and simpler dosing schedules.
• For concerns about sexual side-effects, mirtazapine or bupropion (where suitable) may be preferred alternatives.

Frequently Asked Questions

Is trazodone on the PBS?

PBS listing is formulation- and indication-dependent and can be limited; many scripts are private, so check the PBS schedule or ask your prescriber.

Can I take alcohol while on trazodone?

No — alcohol increases sedation and fall risk and should be avoided until tolerance is established; discuss specific concerns with your pharmacist.

Is trazodone safe for older Australians?

It can be used but start low and titrate slowly, monitor blood pressure and falls risk, and review for polypharmacy; consider alternatives if there is high cardiac or anticholinergic risk.

How quickly does it work for sleep versus mood?

Sleep benefit often occurs within nights at low dose, while mood improvement usually begins within 1–2 weeks and often reaches full effect by 4–6 weeks.

• When To Call GP/Pharmacist: severe dizziness, fainting, signs of serotonin syndrome, priapism, or suicidal thoughts warrant urgent contact.

Guidelines For Proper Use

Pharmacists and prescribers ask for a simple checklist when initiating trazodone.

Confirm the indication clearly — depression versus insomnia — and document whether the sleep use is off-label.

Review current medicines for interactions, especially MAOIs, SSRIs, triptans and potent CYP3A4 inhibitors.

Start at the lowest effective dose and counsel patients about sedation, orthostatic hypotension and driving safety.

Baseline monitoring should include blood pressure and heart rate, falls risk assessment, mood and suicidality checks and hepatic function if clinically indicated.

When stopping, taper gradually to reduce withdrawal; for rural, remote or Indigenous patients coordinate with local health services and consider telehealth follow-up.

Suggested Pharmacist Counselling Script:

• "This medicine is trazodone (Desyrel). Take as prescribed; for sleep we usually start 25–100 mg at night, and for depression we commonly start 150 mg daily. Avoid alcohol, be careful with driving and report dizziness or fainting. If you experience prolonged painful erection, seek urgent care. Check in after one week for blood-pressure monitoring and again at four weeks for response."

Delivery Across Australia